abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
5,215,082
Share change
+946,578
Total reported value
$74,160,302
Price per share
$14.21
Number of holders
79
Value change
+$13,461,137
Number of buys
52
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q4 2022

As of 31 Dec 2022, abrdn Life Sciences Investors - Common (HQL) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,215,082 shares. The largest 10 holders included MORGAN STANLEY, 1607 Capital Partners, LLC, FLAGSHIP HARBOR ADVISORS, LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, WOLVERINE ASSET MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, Cornerstone Advisors, LLC, Advisors Asset Management, Inc., and LAZARD ASSET MANAGEMENT LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.